|Bid||48.51 x 800|
|Ask||131.50 x 1100|
|Day's Range||117.54 - 122.47|
|52 Week Range||104.32 - 187.29|
|Beta (5Y Monthly)||1.20|
|PE Ratio (TTM)||81.78|
|Earnings Date||Jul 27, 2022 - Aug 01, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||160.25|
Subscribe to Yahoo Finance Plus to view Fair Value for OMCL
McKesson's (MCK) latest activities in the oncology care space is expected to serve a wider patient pool.
Omnicell, Axonics and Outset Medical have been highlighted in this Industry Outlook article.
Investors continue to be optimistic about Nevro (NVRO) owing to its strength in the global SCS market.